Skip to main content

08.03.2024 | Original Article

A comparative study of uncomplicated acute non-A-E hepatitis with acute viral hepatitis and acute onset autoimmune hepatitis

verfasst von: Siddhesh Vijay Rane, Shubham Jain, Partha Debnath, Rahul Deshmukh, Sujit Nair, Sanjay Chandnani, Rima Kamat, Pravin Rathi

Erschienen in: Indian Journal of Gastroenterology

Einloggen, um Zugang zu erhalten

Abstract

Background and Aims

Non-A-E hepatitis (NAEH) not leading to acute liver failure (ALF) is poorly documented. The objective was to compare clinical and laboratory features of uncomplicated acute NAEH with acute viral (AVH) and autoimmune hepatitis (AIH) and histopathology in NAEH and AIH.

Methods

Cases of hepatocellular jaundice were included. These were grouped into AVH, AIH and NAEH based on clinical, laboratory and, when indicated, liver biopsy findings. NAEH and AIH were followed up at three months.

Results

Of 336 patients with hepatocellular jaundice, 15 (5%) were NAEH, 25 (7%) acute AIH and 45 (14%) AVH. Among NAEH patients, seven (46.7%) were males with a mean age of presentation 39 years. Jaundice (100%) was the most common presentation of NAEH. Peak bilirubin was 10.7 mg/dL. Peak aspartate and alanine aminotransferase (AST, ALT) were 512 and 670 U/L. Five (33.3%) patients had positive anti-nuclear antibody and one had anti-smooth muscle antibody. Mean immunoglobulin G (IgG) levels were 1829. On liver biopsy, all had ballooning degeneration, four (26.7%) had mild and three (20%) moderate interface hepatitis, four (26.7%) mild lymphoplasmacytic infiltrate, one (6.7%) rosette formation, bridging necrosis in none and stage 1 fibrosis in one. Comparing NAEH with AIH, AIH showed significantly older age at presentation, female predisposition, past history of jaundice, lower ALT, more autoantibodies, higher IgG, higher grade interface hepatitis, lymphoplasmacytic infiltrate, rosette formation and higher bilirubin, AST at three months. NAEH and viral hepatitis had similar features.

Conclusion

Etiology of NAEH is unlikely to be autoimmune and is probably viral, unidentified as yet. Uncomplicated NAEH likely has self-limiting course even without specific treatment.

Graphical abstract

Literatur
1.
Zurück zum Zitat Shalimar, Acharya SK, Kumar R, et al. Acute liver failure of non-A-E viral hepatitis etiology-profile, prognosis, and predictors of outcome. J Clin Exp Hepatol. 2020;10:453–61. Shalimar, Acharya SK, Kumar R, et al. Acute liver failure of non-A-E viral hepatitis etiology-profile, prognosis, and predictors of outcome. J Clin Exp Hepatol. 2020;10:453–61.
2.
Zurück zum Zitat Bernal W, Hyyrylainen A, Gera A, et al. Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol. 2013;59:74–80.CrossRefPubMed Bernal W, Hyyrylainen A, Gera A, et al. Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol. 2013;59:74–80.CrossRefPubMed
3.
Zurück zum Zitat Donaghy L, Barry FJ, Hunter JG, et al. Clinical and laboratory features and natural history of seronegative hepatitis in a nontransplant centre. Eur J Gastroenterol Hepatol. 2013;25:1159–64.PubMed Donaghy L, Barry FJ, Hunter JG, et al. Clinical and laboratory features and natural history of seronegative hepatitis in a nontransplant centre. Eur J Gastroenterol Hepatol. 2013;25:1159–64.PubMed
4.
Zurück zum Zitat Ben-Ari Z, Samuel D, Zemel R, et al. Fulminant non-A-G viral hepatitis leading to liver transplantation. Arch Intern Med. 2000;160:388–92.CrossRefPubMed Ben-Ari Z, Samuel D, Zemel R, et al. Fulminant non-A-G viral hepatitis leading to liver transplantation. Arch Intern Med. 2000;160:388–92.CrossRefPubMed
5.
Zurück zum Zitat Brennan PN, Donnelly MC, Simpson KJ. Systematic review: non A-E, seronegative or indeterminate hepatitis; what is this deadly disease? Aliment Pharmacol Ther. 2018;47:1079–91.CrossRefPubMed Brennan PN, Donnelly MC, Simpson KJ. Systematic review: non A-E, seronegative or indeterminate hepatitis; what is this deadly disease? Aliment Pharmacol Ther. 2018;47:1079–91.CrossRefPubMed
7.
Zurück zum Zitat Miyake Y, Iwasaki Y, Kobashi H, et al. Autoimmune hepatitis with acute presentation in Japan. Dig Liver Dis. 2010;42:51–4.CrossRefPubMed Miyake Y, Iwasaki Y, Kobashi H, et al. Autoimmune hepatitis with acute presentation in Japan. Dig Liver Dis. 2010;42:51–4.CrossRefPubMed
8.
Zurück zum Zitat Muratori P, Carbone M, Stangos G, et al. Clinical and prognostic implications of acute onset of autoimmune hepatitis: an Italian multicentre study. Dig Liver Dis. 2018;50:698–702.CrossRefPubMed Muratori P, Carbone M, Stangos G, et al. Clinical and prognostic implications of acute onset of autoimmune hepatitis: an Italian multicentre study. Dig Liver Dis. 2018;50:698–702.CrossRefPubMed
9.
Zurück zum Zitat Aljumah AA, Al-Ashgar H, Fallatah H, Albenmousa A. Acute onset autoimmune hepatitis: clinical presentation and treatment outcomes. Ann Hepatol. 2019;18:439–44.CrossRefPubMed Aljumah AA, Al-Ashgar H, Fallatah H, Albenmousa A. Acute onset autoimmune hepatitis: clinical presentation and treatment outcomes. Ann Hepatol. 2019;18:439–44.CrossRefPubMed
11.
Zurück zum Zitat Lanini S, Ustianowski A, Pisapia R, Zumla A, Ippolito G. Viral hepatitis: etiology, epidemiology, transmission, diagnostics, treatment, and prevention. Infect Dis Clin North Am. 2019;33:1045–62.CrossRefPubMed Lanini S, Ustianowski A, Pisapia R, Zumla A, Ippolito G. Viral hepatitis: etiology, epidemiology, transmission, diagnostics, treatment, and prevention. Infect Dis Clin North Am. 2019;33:1045–62.CrossRefPubMed
12.
Zurück zum Zitat Bunchorntavakul C, Reddy KR. Epstein-Barr virus and cytomegalovirus infections of the liver. Gastroenterol Clin North Am. 2020;49:331–46.CrossRefPubMed Bunchorntavakul C, Reddy KR. Epstein-Barr virus and cytomegalovirus infections of the liver. Gastroenterol Clin North Am. 2020;49:331–46.CrossRefPubMed
13.
Zurück zum Zitat Then EO, Gayam V, Are VS, Sunkara T, Gaduputi V. Herpes simplex virus hepatitis: a brief review of an Oft-overlooked pathology. Cureus. 2019;11:e4313.PubMedPubMedCentral Then EO, Gayam V, Are VS, Sunkara T, Gaduputi V. Herpes simplex virus hepatitis: a brief review of an Oft-overlooked pathology. Cureus. 2019;11:e4313.PubMedPubMedCentral
15.
Zurück zum Zitat Sarin SK, Choudhury A, Sharma MK, et al. APASL ACLF Research Consortium (AARC) for APASL ACLF working Party. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL): an update. Hepatol Int. 2019;13:353–90.CrossRefPubMed Sarin SK, Choudhury A, Sharma MK, et al. APASL ACLF Research Consortium (AARC) for APASL ACLF working Party. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL): an update. Hepatol Int. 2019;13:353–90.CrossRefPubMed
16.
Zurück zum Zitat Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2020;71:306–33.CrossRefPubMed Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2020;71:306–33.CrossRefPubMed
17.
Zurück zum Zitat Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67:1560–99.CrossRefPubMed Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67:1560–99.CrossRefPubMed
18.
Zurück zum Zitat Mack CL, Adams D, Assis DN, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases. Hepatology. 2020;72:671–722.CrossRefPubMed Mack CL, Adams D, Assis DN, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases. Hepatology. 2020;72:671–722.CrossRefPubMed
19.
Zurück zum Zitat Ganger DR, Rule J, Rakela J, et al. Acute Liver Failure Study Group. Acute liver failure of indeterminate etiology: a comprehensive systematic approach by an expert committee to establish causality. Am J Gastroenterol. 2018;113:1319.CrossRefPubMedPubMedCentral Ganger DR, Rule J, Rakela J, et al. Acute Liver Failure Study Group. Acute liver failure of indeterminate etiology: a comprehensive systematic approach by an expert committee to establish causality. Am J Gastroenterol. 2018;113:1319.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Alter MJ, Gallagher M, Morris TT, et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. Sentinel Counties Viral Hepatitis Study Team. N Engl J Med. 1997;336:741–6.CrossRefPubMed Alter MJ, Gallagher M, Morris TT, et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. Sentinel Counties Viral Hepatitis Study Team. N Engl J Med. 1997;336:741–6.CrossRefPubMed
21.
Zurück zum Zitat Delić D, Mitrović N, Spurnić AR, Svirtlih NS, Babić JS. Epidemiological characteristics and clinical manifestations of acute non-A-E hepatitis. Vojnosanit Pregl. 2010;67:903–9.CrossRefPubMed Delić D, Mitrović N, Spurnić AR, Svirtlih NS, Babić JS. Epidemiological characteristics and clinical manifestations of acute non-A-E hepatitis. Vojnosanit Pregl. 2010;67:903–9.CrossRefPubMed
22.
Zurück zum Zitat Paraná R, Codes L, Andrade Z, et al. Clinical, histologic and serologic evaluation of patients with acute non-A-E hepatitis in north-eastern Brazil: is it an infectious disease? Int J Infect Dis. 2003;7:222–30.CrossRefPubMed Paraná R, Codes L, Andrade Z, et al. Clinical, histologic and serologic evaluation of patients with acute non-A-E hepatitis in north-eastern Brazil: is it an infectious disease? Int J Infect Dis. 2003;7:222–30.CrossRefPubMed
23.
Zurück zum Zitat Nagral N, Joshi V, Baria K, et al. Prevalence of non A to E hepatitis in Mumbai, India. Rev Gastroenterol Peru. 2018;38:49–53.PubMed Nagral N, Joshi V, Baria K, et al. Prevalence of non A to E hepatitis in Mumbai, India. Rev Gastroenterol Peru. 2018;38:49–53.PubMed
25.
Zurück zum Zitat Sonthalia N, Rathi PM, Jain SS, et al. Natural history and treatment outcomes of severe autoimmune hepatitis. J Clin Gastroenterol. 2017;51:548–56.CrossRefPubMed Sonthalia N, Rathi PM, Jain SS, et al. Natural history and treatment outcomes of severe autoimmune hepatitis. J Clin Gastroenterol. 2017;51:548–56.CrossRefPubMed
26.
Zurück zum Zitat Abutaleb A, Kottilil S. Hepatitis A: epidemiology, natural history, unusual clinical manifestations, and prevention. Gastroenterol Clin North Am. 2020;49:191–9.CrossRefPubMedPubMedCentral Abutaleb A, Kottilil S. Hepatitis A: epidemiology, natural history, unusual clinical manifestations, and prevention. Gastroenterol Clin North Am. 2020;49:191–9.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Menzo S, Minosse C, Vincenti D, et al. Long-term follow-up of acute hepatitis B: new insights in its natural history and implications for antiviral treatment. Genes (Basel). 2018;9:293.CrossRefPubMedPubMedCentral Menzo S, Minosse C, Vincenti D, et al. Long-term follow-up of acute hepatitis B: new insights in its natural history and implications for antiviral treatment. Genes (Basel). 2018;9:293.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Borse NC, Rathi PM, Sawant P. Hepatitis G virus: an innocent contaminant. J Assoc Physicians India. 1999;47:721–3.PubMed Borse NC, Rathi PM, Sawant P. Hepatitis G virus: an innocent contaminant. J Assoc Physicians India. 1999;47:721–3.PubMed
30.
Zurück zum Zitat Tassopoulos NC, Papatheodoridis GV, Delladetsima I, Hatzakis A. Clinicopathological features and natural history of acute sporadic non-(A-E) hepatitis. J Gastroenterol Hepatol. 2008;23 8 Pt 1:1208–15. Tassopoulos NC, Papatheodoridis GV, Delladetsima I, Hatzakis A. Clinicopathological features and natural history of acute sporadic non-(A-E) hepatitis. J Gastroenterol Hepatol. 2008;23 8 Pt 1:1208–15.
Metadaten
Titel
A comparative study of uncomplicated acute non-A-E hepatitis with acute viral hepatitis and acute onset autoimmune hepatitis
verfasst von
Siddhesh Vijay Rane
Shubham Jain
Partha Debnath
Rahul Deshmukh
Sujit Nair
Sanjay Chandnani
Rima Kamat
Pravin Rathi
Publikationsdatum
08.03.2024
Verlag
Springer India
Erschienen in
Indian Journal of Gastroenterology
Print ISSN: 0254-8860
Elektronische ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-023-01474-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.